# Mario E. Lacouture

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mario-e-lacouture/

## Facts

| Field | Value |
| --- | --- |
| Citations | 29,104 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 88 |
| i10-index | 284 |
| Last Known Institution | Garden City Community College |
| OpenAlex ID | https://openalex.org/A5002599922 |
| ORCID iD | https://orcid.org/0000-0002-4818-3710 |
| Works | 703 |

## Researcher papers

- [Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events](https://scholariq.org/papers/society-for-immunotherapy-of-cancer-sitc-clinical-practice-guideline-on-immune/)
- [Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/management-of-immunotherapy-related-toxicities-version-1-2019-nccn-clinical/)
- [Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)](https://scholariq.org/papers/cutaneous-keratoacanthomas-squamous-cell-carcinomas-associated-with/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Chemotherapy-related skin toxicity](https://scholariq.org/topics/chemotherapy-related-skin-toxicity/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Nonmelanoma Skin Cancer Studies](https://scholariq.org/topics/nonmelanoma-skin-cancer-studies/)

## Researcher university

- [Garden City Community College](https://scholariq.org/institutions/garden-city-community-college/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
